Actavis, Inc. News Headlines

ACT 
$291.36
*  
1.58
0.55%
Get ACT Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading ACT now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
AstraZeneca Unveils $600M Deal To Buy Actavis' Lung Drugs
2/5/2015 3:05:00 PM - Seeking Alpha


Millennium Management exits position in Procter & Gamble
2/5/2015 2:05:00 PM - Market Realist


Pfizer To Buy Hospira For $15.23 Bln
2/5/2015 12:45:00 PM - RTT News


European Markets Finished Mixed On Renewed Greek Concerns
2/5/2015 12:03:00 PM - RTT News


Predictable Fast Growing Healthcare Dividend Growth And Growth Stocks For Your Retirement Portfolios: Part 5
2/5/2015 11:51:00 AM - Seeking Alpha


Millennium Management exits stake in Forest Laboratories
2/5/2015 11:06:00 AM - Market Realist


Today's Market: Mergers And Acquisitions Driving Markets And These Stocks Higher
2/5/2015 10:33:00 AM - Seeking Alpha


AstraZeneca Q4 Adj. Profit Misses View, To Buy Actavis'' Respiratory Drug Unit
2/5/2015 10:20:00 AM - RTT News


DPLO To Dispense Breast Cancer Drug, New Use For Old Drugs Sought, CANF On Watch
2/5/2015 8:12:00 AM - RTT News


AstraZeneca to Buy Actavis's Respiratory Drug Business in U.S., Canada -- 2nd Update
2/5/2015 6:39:00 AM - Dow Jones Business News


AstraZeneca to Buy Actavis''s Respiratory Drug Business in U.S., Canada -- 2nd Update
2/5/2015 6:39:00 AM - Dow Jones Business News


European Shares Fall On Greek Uncertainty
2/5/2015 6:17:00 AM - RTT News


AstraZeneca To Buy Actavis'' U.S. Respiratory Portfolio - Quick Facts
2/5/2015 2:24:00 AM - RTT News


Allergan Profit Surges On Higher Sales Ahead Of Actavis Takeover
2/4/2015 5:59:00 PM - Dow Jones Business News


Actavis Says FDA Accepts SNDA To Expand TEFLARO Labeling - Quick Facts
2/4/2015 8:11:00 AM - RTT News


3 Reasons To Buy Actavis Plc
2/3/2015 9:57:00 AM - Seeking Alpha


Seeking Alpha's Biotech Weekly: Intercept Pops, Provenge's Prince Valeant, And More
1/30/2015 4:00:00 PM - Seeking Alpha


Valeant to Buy Prostate-Cancer Drug From Dendreon
1/29/2015 11:15:00 PM - Dow Jones Business News


Valeant in Deal to Buy Prostate-Cancer Drug Provenge From Dendreon
1/29/2015 10:54:00 PM - Dow Jones Business News


$CTIX - Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon
1/29/2015 4:13:00 PM - Seeking Alpha


Elite Pharmaceuticals Is Well Positioned To Address $7B Abuse Deterrent Opioid Market
1/29/2015 8:06:00 AM - Seeking Alpha


Will Abbott Labs (ABT) Disappoint on Earnings This Quarter? - Analyst Blog
1/28/2015 6:30:00 AM - Investopedia


Is AbbVie (ABBV) Set to Beat 4Q Earnings on Humira Sales? - Analyst Blog
1/28/2015 5:50:00 AM - Investopedia


Pfizer Hit by Stronger Dollar, Patent Losses -- 2nd Update
1/27/2015 4:21:00 PM - Dow Jones Business News


Will Biogen (BIIB) Surpass Q4 Earnings Expectations? - Analyst Blog
1/27/2015 12:00:00 PM - Investopedia